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Purpose: Our previous report demonstrated that ethambutol (EMB) might induce cytoplasmic vacuolization and reduce
the uptake of photoreceptor rod outer segments (ROS) in retinal pigment epithelium (RPE) cells, which are mediated via
a protein kinase C (PKC)-dependent pathway. In the present study, we sought to identify the PKC isozyme(s) involved.
Methods: EMB-induced cytoplasmic vacuolization and uptake of ROS were observed under a phase contrast microscope.
Western blots were performed to observe the membrane translocation of PKC isozymes and cytoplasmic release of
cathepsin D. Quantitative PCR were performed to analyze gene expression of PKCδ. Human RPE cell line RPE50 and
ARPE19 cells were pretreated with specific inhibitors or transfected with shRNAs of various PKC isozymes, including
PKCα, β, ε, γ, and δ, to examine whether EMB-induced toxic effects were prevented.
Results: In RPE50 cells, gene expression of PKCδ on both mRNA and protein levels was induced by EMB within 30 min
to 3 h. EMB-induced cytoplasmic vacuolization in both RPE50 and ARPE19 cells was prevented by pretreating the cells
with a specific inhibitor of PKCδ, Rottlerin, or depletion of PKCδ by shRNA. EMB-triggered reduction of ROS uptake
was also significantly suppressed by pretreatment with Rottlerin, or depletion of PKCδ by shRNA technology. In contrast,
pretreatment of the cells with specific inhibitors of PKCα, β, ε, or γ, or depletion of PKCα or β didn’t influence the
aforementioned EMB-triggered toxic effects. In addition, in RPE50, EMB induced the release of lysosomal enzyme
cathepsin D into cytosol within 30 min to 6 h, which was also prevented by Rottlerin.
Conclusions: EMB-induced vacuole formation, cytoplasmic release of cathepsin D, and reduction of phagocytosis in
RPE are intimately correlated and regulated by the PKCδ signal pathway.
Ethambutol  (EMB)  is  routinely  used  as  an  anti-
mycobacterial  agent,  especially  in  the  treatment  of
tuberculosis. However, EMB can cause vision impairment,
ethambutol-induced optic neuropathy (EON), in 1%–5% of
patients [1]. Some patients have suffered irreversible vision
loss [2,3].
It has been suggested that the cause of EON might be
associated with disturbance of the optic nerve that is induced
by EMB via an excitotoxicity pathway [4-9]. However, the
toxic effects of EMB on retinal cells were also highlighted in
recent studies [10-13]. For example, one clinical study that
used  multifocal  electroretinography  (mfERG)  to  examine
EON patients suggested that the visual dysfunction might be
entirely attributable to toxicity of the retina rather than optic
nerve [11]. Another study demonstrated an obvious retinal
abnormality  in  EON  patients,  including  retinal  pigment
epithelial  change,  macular  edema,  and  flame-shaped
hemorrhages consistent with abnormal ERG findings [13].
Moreover, it was reported that 55.6% (15/27) of patients with
EON  had  an  abnormal  Arden  ratio  in  electrooculography
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(EOG) examinations, which indicated that EMB can cause
retinal pigment epithelial (RPE) cell dysfunction [14]. In the
retina, the RPE is located between the choroid capillary layer
and the light-sensitive outer segments of the photoreceptors,
and is supposed to be the area most susceptible to EMB-
induced pathological effects. Indeed, our recent studies have
demonstrated that EMB may induce toxic effects such as
cytosolic vacuolization and reduced phagocytic activity in
human  RPE-derived  cells,  including  RPE50  and  ARPE19
[12]. We also found that protein kinase C (PKC) activity can
be  induced  by  EMB  and  is  required  for  EMB-induced
vacuolar  formation;  however,  the  PKC  isozyme(s)
responsible  for  the  EMB-induced  toxic  effects  remain(s)
unidentified.
Thus far, at least 12 isoforms of tissue-specific PKC have
been found and can be divided into three major groups: the
classic PKCs (cPKC: PKCα, PKCβI, PKCβII, and PKCγ), the
novel PKCs (nPKC: PKCδ, PKCε, PKCη, PKCθ), and the
atypical PKCs (aPKC: PKCζ, PKCλ, and PKCι) [15,16]. Ten
of the PKC isozymes are present in cultured human RPE cells
[17]. Among them, PKCα, PKC βII, PKCδ, and PKCε have
been reported to be associated with pathological effects of
RPE [18]. In the present study, we sought to identify which
PKC isozyme is responsible for the toxic effects of EMB on
RPE.
Molecular Vision 2011; 17:1564-1576 <http://www.molvis.org/molvis/v17/a175>
Received 10 December 2010 | Accepted 6 June 2011 | Published 9 June 2011
© 2011 Molecular Vision
1564METHODS
Human RPE cell line: RPE50 is a primary culture of human
RPE cells provided by the Tissue Culture Center, New York
Eye and Ear Infirmary. This cell line was isolated from an
anonymous donor sample not referable to any patient [19].
RPE50 has been used for studying the effects of oxidative
stress on ion channels [20] and also for cell cycle analysis and
gene  expression  [21].  ARPE19,  purchased  from  the
Bioresource  Collection  and  Research  Center  (BCRC,
Hsinchu, Taiwan) is more differentiated than RPE50, having
been characterized by ZO-1 and RPE65, two differentiation
markers of RPE, in our previous study [12]. Both cell lines
were maintained in a 1:1 mixture of Dulbecco’s Modified
Eagle’s Medium (DMEM) and a F12 medium containing 1.2
g/l sodium bicarbonate, 2.5 mM L-glutamine, 15 mM 4-(2-
hydroxyethyl)-1-piperazine-ethanesulfonic  acid  (HEPES),
0.5 mM sodium pyruvate, and 10% fetal bovine serum (FBS).
Chemicals  and  antibodies:  Ethambutol  dihydro-chloride
(EMB), TCPK-trypsin, and soybean trypsin inhibitor were
purchased  from  Sigma  (St.  Louis,  MO).  Various  PKC
isozyme inhibitors, including Rottlerin, Go6976, Ro32–0432,
RBX,  bisindolymaleimide,  DAPH-7,  and  HBDDE  were
purchased  from  Calbiochem  (La  Jolla,  CA).  Antibodies
against PKCα, β, γ, δ and cathepsin D were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA).
Fractionation of the cellular extract.
The  cytosolic  and  membrane  fraction—Briefly,  the
cells were suspended in a hypotonic buffer (10 mM Tris in pH
7.4, 50 mM NaCl, 0.3 mM Na-orthovanadate, 50 mM NaF,
1 mM DTT, 10 g/ml leupeptin, and 5 ug/ml aprotinin) and
incubated at 4 °C for 30 min. The cell suspensions were
homogenized  and  centrifuged  at  594  ×g  for  3  min.  The
supernatants  were  then  subjected  to  ultracentrifugation  at
22190 ×g for 1 h, and the resulting supernatants obtained
provided  the  cytosolic  fraction.  The  pellets  were  then
dissolved in a lysis buffer containing 50 mM Tris, 50 mM
NaCl,  1%  Triton  X-100,  0.1%  SDS,  0.3  mM  Na-
orthovanadate, 50 mM NaF, 1 mM DDT, 10 μg/ml leupeptin,
and 5 μg/ml aprotinin. Following a second centrifugation at
22190× g for 1 h, the supernatants obtained provided the
membrane fraction.
The lysosomal fraction—The crude lysosomal fraction
was prepared according to the protocol of a Lysosme Isolation
Kit  (Sigma)  but  with  some  modification.  Briefly,  the
harvested cells were broken by freezing and thawing in the
lysis buffer at −80 °C, followed by centrifugation at 1,000× g
for  10  min.  The  pellet  from  the  cell  fragmentation  was
discarded  and  the  supernatant  was  centrifuged  again  at
20,000× g for 20 min. The pellet was then re-suspended in a
lysis buffer for crude lysosomal fraction (CLF) containing a
mixture  of  mitochondria,  lysosomes,  peroxisomes,  and
endoplasmic reticulum.
Immunoblotting:  Immunoblotting  was  performed  using  a
standard procedure. Briefly, the cells were lysed and equal
amounts of protein in each sample were separated by 12%
SDS/PAGE,  and  then  transferred  to  PVDF  membranes.
Membranes were blocked in 5% dry milk and were probed
with  antibodies  against  molecules  of  interest.  Following
incubation  with  an  alkaline  phosphatase-conjugated
secondary antibody, proteins were visualized with NBT/BCIP
for color development. For quantization, the intensity of each
specific band was estimated using gel digitizing software,
UN-SCAN-IT gel version 5.1.
Quantitative RT/PCR: Cellular mRNA was purified with an
Ultraspec  kit  (Biotech,  Houston,  TX)  followed  by  cDNA
synthesis using Reverse-itTM (ABgene, Surrey, UK). Real-
time PCR of PKCδ was performed using a QuantiTect SYBR
PCR kit (Qiagen, Crawley, UK) in an ABI 7300 real-time PCR
system (Applied Biosystems, Foster City, CA).
PCR mixtures were preincubated at 95 °C for 15 min to
activate the polymerase (Qiagen, Valencia, CA). Each of the
40 PCR cycles consisted of 16 s of denaturation at 94 °C,
annealing of primers for 30 s at 55 °C, and 15 s of extension
at 72 °C. The relative amounts of mRNA were calculated by
the  7300  system  SDS  Software  using  glyceraldehyde  3-
phosphate dehydrogenase (GAPDH) as the internal control.
The primer sequences used for PKCδ and GAPDH were:
5′-GAA GCA GGG ATT AAA GTG TG-3′ and reverse: 5′-
TTC TTC TCG AAA CCC TGA TA-3′ (192 bp). GAPDH
forward: 5′-CGG AGT CAA CGG ATT TGG TCG TAT-3′
and  reverse:  5′-AGC  CTT  CTC  CAT  GGT  GGT  GAA
GAC-3′ (301 bp).
Observation and quantitation of cytoplasmic vacuolization:
For comparison of the extent of cytoplasmic vacuolization
exhibited in RPE cells under various treatments (Figure 1 and
Figure  2),  the  number  of  vacuoles  within  90%–100%  of
confluent cells under the 200× magnification field of a phase
contrast microscope were counted. Eight fields per well (of a
24-well plate) were scored and averaged (data not shown).
The average number of vacuoles/per field were compared
between indicated treatment groups using one way ANOVA
followed by Dunnett’s post hoc test. Each experiment was
repeated and validated by two other investigators, both of
whom  were  unaware  of  the  treatment  groups  before
microscopic observation.
Photoreceptor rod outer segments (ROS) preparation: ROS
were  prepared  according  to  previous  reports  but  with
modifications [22]. Briefly, retinas from 10 fresh pig eyes
obtained from a local slaughterhouse were prepared under dim
red  light.  The  retinas  were  dissected  and  placed  in  a
homogenizing  solution  (20%  W/V  sucrose,  20  mM  Tris
acetate (pH 7.2), 2 mM MgCl2, 10 mM glucose, and 5 mM
taurine),  followed  by  filtration  through  cheesecloth.  The
filtrates were layered on 25%–60% W/V continuous sucrose
gradients containing 20 mM Tris acetate (pH 7.2), 10 mM
glucose, and 5 mM taurine, and were then centrifuged at
22190× g for 45 min at 4 °C. A single pink band in the upper
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buffer (PH7.2) by fivefold, and centrifuged at 2375× g for 10
min. The pellets were resuspended in 1 ml of 0.02 M Tris
buffer (pH 7.2) and digested with TCPK-trypsin at 23 °C for
15 min. The reaction was then stopped by the addition of
10 μl of soybean trypsin inhibitor (4 mg/ml). The trypsin-
treated ROS were washed with 10 ml of 0.02 M Tris buffer
(pH 7.2) containing 10% sucrose by centrifugation at 7988×
g  for  10  min.  The  ROS  pellets  were  resuspended  at  a
concentration of approximately 4 mg/ml in 0.02 M sodium
phosphate (pH 7.2) containing 10% W/V sucrose and were
stored at −80 °C.
In vitro phagocytosis assay: Phagocytosis of ROS by RPE was
performed according to previous reports [23]. The ROS were
labeled with 1 mg/ml of fluorescein isothiocyanate (FITC,
Molecular Probes) in 0.1 M NaCO3 (pH 9.0), for 1 h in the
dark,  followed  by  washing  and  re-suspension  in  the  cell
culture  medium  with  2.5%  sucrose  at  a  concentration  of
5×107 ROS/ml. The labeled ROS (2×106) were incubated with
RPE cells in 50 μl of the culture medium containing 2.5%
sucrose.  Phagocytosis  was  allowed  to  occur  for  the
experimental times indicated. At the end of each time period,
the  cells  were  incubated  with  0.2%  trypan  blue  in  PBS
containing 1 mM MgCl2 and 0.2 mM CaCl2 (PBS-CM) for 10
min  to  quench  the  FITC  fluorescence  derived  from  the
externally bound particles [24]. The cells were then fixed by
ice-cold  methanol  for  5  min,  followed  by  3%
paraformaldehyde  in  PBS-CM  for  10  min  at  room
temperature.  Finally,  nuclei  were  stained  with  1  μg/ml
propidium iodide (PI) in PBS-CM for 20 min; samples were
Figure 1. Protein kinase C (PKC)δ was
required for ethambutol (EMB)-induced
vacuolar  formation  in  retinal  pigment
epithelium  (RPE).  RPE50  (A)  or
ARPE19  (C)  cells  were  untreated
(denoted  as  C),  treated  with  8.0  mM
EMB alone, or EMB plus the indicated
inhibitors of PKC isozymes for 24 h.
Pictures  were  taken  under  a  phase
contrast  microscope  with  200×
magnification.  This  result  is
representative  of  three  reproducible
experiments.  (B)  and  (D)  are
quantitations  of  cytoplasmic
vacuolization  for  (A)  and  (C),
respectively, performed as described in
Methods. The number of vacuoles/per
field were compared between indicated
treatment  groups  using  one  way
ANOVA  followed  by  Dunnett’s  post
hoc  tests.  The  asterisks  (*  and  **)
indicate statistical significance (p<0.05
and  p<0.005,  respectively,  n=3)
between the indicated groups.
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(200×  magnification;  Olympus,  Tokyo,  Japan).  For
quantization,  the  number  of  ROS  and  cells  were  counted
separately.  The  phagocytic  activity  (ROS  uptake)  was
calculated as the average of the number of ROS/cell in 8
randomly selected fields. The relative phagocytic activity in
each experimental group was defined as the value for ROS
uptake divided by those of the control RPE.
shRNA technology for depletion of PKC isozymes: Lentiviral
plasmids encoding shRNAs targeting different regions of the
indicated mRNA were obtained from RNAi Core Laboratory
in Academia Sinica, Taiwan. Cells at 60% confluence were
transfected with 0.26 ng/μl effective shRNAs, either alone or
in  combination,  using  Effectene  transfection  reagent
(Invitrogen  Ltd,  Renfrew,  UK)  according  to  the
manufacturer's  protocol.  The  required  treatments  were
performed after the cells were transiently transfected with
shRNAs for 36 h. The target sequence of each of the shRNA
fragments for PKCα, PKCβII, and PKCδ used in this study
are listed in Table 1.
Statistical analysis: Paired Student's t tests were conducted to
statistically  analyze  quantitative  RT/PCR  (Figure  3)  and
relative ROS uptake (Figure 4&,D) betweenWheLndicated
groups. All quantitative studies were performed at least in
triplicate,  with  the  results  expressed  as  the  mean±SD  as
appropriate. The preventive effects of various inhibitors or the
shRNA  of  PKC  isozymes  on  EMB-induced  cytoplasmic
vacuolization (Figure 1 and Figure 2) were evaluated by one-
Figure 2. Depletion of protein kinase C
(PKC)δ prevented ethambutol (EMB)-
induced  vacuolar  formation.  Retinal
pigment  epithelium  (RPE)50  (A)  or
ARPE19 (C) and (D) were transfected
with none (MOCK), shRNA of lamin
(control  shRNA),  or  combinations  of
shRNA fragments of PKCα (90/92 in
A),  PKC  βII  (D/A2  in  A  and  C),  or
PKCδ (F/H, G/H in A and E/G in C), for
36 h followed by treatment with 0.8 mM
EMB for 24 h. Pictures were taken under
a phase contrast microscope with 200×
(A, C) and 400× (D) magnification. (B)
and (E) are quantitations of cytoplasmic
vacuolization  for  (A)  and  (D),
respectively, performed as described in
Methods.  These  results  are
representative  of  five  reproducible
experiments. The number of vacuoles/
per  field  were  compared  between
indicated  treatment  groups  using  one
way  ANOVA  followed  by  Dunnett’s
post hoc tests. The asterisks (* and **)
indicate statistical significance (p<0.05
and  p<0.005,  respectively,  n=5)
between the indicated groups.
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Differences were considered to be significant at p<0.05. One
or two asterisks (* and **) indicate statistical significance
(p<0.05 and p<0.005, respectively) between groups.
RESULTS
PKCδ  activity  was  required  for  EMB-induced  vacuolar
formation in RPE: Previously, we have demonstrated that
EMB could induce PKC-dependent cytotoxic effects such as
cytoplasmic  vacuolization  in  two  human  RPE  cell  lines,
RPE50  and  ARPE19.  We  further  screened  for  the  PKC
isozyme(s) responsible for the EMB-induced vacuolization,
using various pharmacological inhibitors of PKC isozymes,
including PKCα, β, γ, δ, and ε (Table 2). RPE50 cells were
pretreated with 2 μM of Rottlerin (for PKCδ, IC50=2–6 μM),
5 nM Go6976 (for PKCα, β, and γ, IC50=2–10 nM), 28 nM
Ro32–0432 (for PKCα and βI, IC50=9 nM, 28 nM), 2 μM RBX
(PKCβII, IC50=1–2 μM), 5uM bisindolymaleimide (BIS; for
PKCα, δ, ζ, η, and ε, IC50=1–5 μM), 500 nM DAPH-7, (for
PKCβII and βI, IC50=410 nM, 3.8 μM) or 50 μM HBDDE (for
PKCα and γ, IC50=43 μM, 50 μM) to observe whether EMB-
triggered  vacuolization  in  RPE  can  be  prevented.  As
demonstrated in Figure 1A,B, the vacuolar formation induced
by EMB was very prominent at 24 h and was suppressed by
61%  in  RPE50  cells  pre-treated  with  2  μM  of  Rottlerin
(p<0.005,  ANOVA).  Pretreatment  of  RPE50  with  BIS
exhibited partially suppressive effects on vacuolar formation
(by 26%; p<0.05, ANOVA), and the vacuoles were smaller
than those observed in the “EMB-treated only” group. In
contrast,  EMB-induced  vacuolization  could  not  be
significantly prevented in RPE50 pre-treated with inhibitors
of  other  PKC  isozymes,  including  Go6976,  Ro32–0432,
TABLE 1. THE TARGET SEQUENCE OF SHRNA FRAGMENTS FOR PKCΑ, ΒII, AND δ
PKC isozyme Fragment name Targeting sequence
PKCα 90 CTTTGGAGTTTCGGAGCTGAT
  92 CATGGAACTCAGGCAGAAATT
PKCβ D CTATCCCAAGTCTATGTCCAA
  A2 GCTGAAAGAATCGGACAAAGA
PKCδ E GGCCGCTTTGAACTCTACCGT
  F CAAGGCTACAAATGCAGGCAA
  G GCAAGACAACAGTGGGACCTA
  H GCAGGGATTAAAGTGTGAAGA
Figure 3. Ethambutol (EMB) did not induce membrane translocation of various protein kinase C (PKC) isozymes but did induce gene
expression of PKCδ in retinal pigment epithelium (RPE). RPE50 cells were treated with 8.0 mM EMB for 0, 0.5, 1 and 3 h. Western blots of
cytosolic and membrane PKCα, βII, and δ (A), and real time RT/PCR (B) of PKCδ were performed. In (A), ERK and tubulin were included
as internal controls for cytosolic and membrane proteins, respectively. The results are representative of four repeated experiments. In (B),
relative amounts of PKCδ mRNA for each sample were calculated, taking the sample of time zero as 1.0. The asterisks (* and **) indicate
statistical significance (p<0.05 and p<0.005, respectively, n=3) between the indicated groups.
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1568Figure 4. Inhibition or depletion of protein kinase C (PKCδ) prevented ethambutol (EMB)-induced suppression of the uptake of rod outer
segments (ROS) in RPE50 cells. The phagocytosis assay was performed in RPE50. In (A) the fluorescein isothiocyanate (FITC)-labeled ROS
were added to the cells in the absence (con) or presence of EMB alone, or EMB plus various PKC isozymes (as indicated) for 2.5 h. In (B),
the cells were untransfected (con), transfected with shRNA of control (lamin), or various PKC isozymes for 36 h, followed by the addition of
the FITC-labeled ROS added in the absence (CON) or presence of EMB for 2.5 h. The FITC-labeled ROS (green dot) up-take by the cells
was observed under a phase contrast microscope (200× magnification). The nuclei were stained with PI (red) as counterstaining. The figures
shown are representative of six to eight repeated experiments. (C) and (D) exhibit quantitative data for (A) and (B), respectively. The extent
of ROS uptake was expressed as ROS/cell obtained from the average of the number of ROS and the cells in eight fields, under a phase contrast
microscope. The asterisks (* and **) indicate statistical significance (p<0.05 and p<0.005, respectively, n=7) between the indicated groups.
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Similar results were obtained using the more differentiated
RPE, ARPE19, as the target cells. As demonstrated in Figure
1C,D,  pretreatment  of  ARPE19  with  2  μM  of  Rottlerin
abolished  EMB-induced  vacuolization  by  91%  (p<0.005,
ANOVA) whereas pretreatment of ARPE19 with BIS resulted
in  partial  suppression  of  EMB-induced  vacuolization  (by
37%; p<0.05, ANOVA) and formation of smaller vacuoles as
compared with that induced by EMB. In contrast, Go6976,
Ro32–0432,  RBX,  DAPH-7,  or  HBDDE  didn’t  exhibit  a
significant preventive effect on EMB-induced vacuolization
(Figure 1C,D and Figure 5B). Taken together, these results
suggested that PKCδ activity was specifically required for
EMB-triggered vacuolization in both RPE50 and ARPE 19.
EMB induced gene expression of PKCδ in RPE50: We then
investigated which PKC isozyme(s) could be activated by
EMB by observing whether any of them exhibited “cytosol to
membrane  translocation,”  which  is  indicative  of  PKC
TABLE 2. VARIOUS PKC ISOZYME INHIBITORS
Inhibitors PKC isozyme IC50*
Bisindolymaleimide (PKC α, δ, ζ, η, ε) 2–5 μM
Go6976 (PKCα.β.γ) 2–10 nM
Rottlerin (PKCδ) 3–6 μM
HBDDE (PKCα.γ) 43 μM, 50 μM
DAPH-7 (PKCβII.βI) 410 nM, 3.8 μM
Ro32–0432 (PKCα. βI) 9 nM, 28 nM
RBX (PKC βII) 1–2 μM
               *IC50: concentration for 50% inhibition.
Figure 5. Inhibitors of protein kinase C (PKC) isozymes other than PKC δ could not prevent ethambutol (EMB)-induced vacuolar formation
in retinal pigment epithelium (RPE). RPE50 (A) and ARPE19 (B) cells were untreated (CON), treated with 8 mM EMB, or EMB plus various
PKC isozymes as indicated, for 24 h. Pictures were taken under a phase contrast microscope with 200× magnification. This result is
representative of three reproducible experiments.
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1570activation in various cell types, including RPE cells [25]. As
demonstrated  in  western  blots  for  both  the  cytosolic  and
membrane  fraction  of  RPE50  cells,  neither  a  decrease  in
cytosolic or an increase in membrane fraction of PKCα, β-II,
or ε was observed after treatment with EMB within 1 to 3 h
(Figure 3A). Surprisingly, PKCδ significantly increased in
both  cytosolic  and  membrane  fractions  after  treatment  of
EMB for 30 min and showed a 3–4 fold increase within 1 to
3 h (Figure 3A). Extended time-course analysis demonstrated
that the EMB-induced elevation of membrane PKCδ was still
observed at 6 h and was sustained until 24 h (Figure 6). These
results implied that the gene expression of PKCδ in RPE50
was upregulated by EMB. Indeed, PKCδ mRNA showed a
twofold elevation after treatment with EMB for 30 min and
this declined to a 1.75 and 1.25 fold elevation at 1 and 3 h,
respectively, as shown by real time RT/PCR (Figure 3B).
Transfection of shRNA of PKCδ but not of other PKC isozymes
prevented EMB-induced vacuolar formation in RPE50 and
ARPE19: To this stage in the study, it appeared that PKCδ was
the  only  PKC  isozyme  induced  by  EMB  to  mediate
cytoplasmic vacuolization. We further investigated whether
blocking of PKCδ expression could prevent EMB-induced
vacuolization in RPE50. Various small hairpin RNA (shRNA)
fragments of PKCδ, PKCα, and PKCβII targeting different
regions on each mRNA, either alone or in combination (with
two fragments), were screened for their efficiency to knock
down each isozyme. As demonstrated in the western blot
(Figure  7),  transient  transfection  of  RPE50  cells  with
combined shRNA fragments of PKCα (90 plus 92), PKCβII
(D plus A2), or PKCδ (F plus H, G plus H or G plus E) for 36
h  could  effectively  depress  the  expression  of  each  PKC
isozyme by between 50%–65% as compared with those in the
MOCK-transfected cells. However, single shRNA fragments
of  PKCα  and  PKCδ  did  not  exhibit  significant  depletion
efficiency. Subsequently, the effective shRNA combinations
were transiently transfected into RPE50 for 36 h and this was
followed by EMB treatment. As demonstrated in Figure 2A,B,
the  EMB-induced  vacuolization  in  RPE50  at  24  h  was
dramatically suppressed in the cells transfected with PKCδ
shRNA (F plus H or G plus H), by between 60%–65% as
compared with that of RPE50 transfected with control (lamin)
shRNA (p<0.005, ANOVA). In contrast, transfection of the
cells with shRNA of PKCα (90 plus 92) and PKCβII (D plus
A2)  did  not  show  significant  preventive  effects.  Similar
results were obtained using ARPE19. As demonstrated in
Figure 2C,E, the EMB-induced vacuolization in ARPE19 at
24 h was suppressed by 57% in the cells transfected with
shRNA (E plus G) of PKCδ but not PKCβII (D plus A2), as
compared with those observed in cells transfected with control
(lamin)  shRNA  (p<0.05,  ANOVA).  The  magnification  of
Figure  2C  was  increased  and  is  provided  in  Figure  2D,
demonstrating  a  clearer  observation  of  the  vacuoles.  The
efficiency of PKCδ shRNA (F plus H or G plus H) for blocking
EMB-induced vacuolization was not so prominent in ARPE19
(data not shown) as it was for those observed in RPE50 and
is probably due to different cell contexts.
PKCδ  inhibitors  and  shRNA  rescued  the  EMB-induced
reduction of ROS uptake in RPE50 and ARPE19: Previously,
we found that EMB may decrease the phagocytic activity of
RPE50 as revealed by a reduction in the uptake of rod outer
segments (ROS) after treatment with EMB for 2.5 to 5 h
[12]. Thus, we further investigated whether this effect was
also mediated by PKCδ. As demonstrated in Figure 4A,B,
treatment of RPE50 with EMB for 2.5 h suppressed the ability
of RPE to uptake ROS by 44%. Pre-treatment of the cells with
BIS  and  Rottlerin  (but  not  inhibitors  of  the  other  PKC
isozymes)  significantly  precluded  the  EMB-triggered
reduction of ROS uptake by 36 and 40%, respectively (Figure
4A,B). Furthermore, suppression of ROS uptake by EMB was
attenuated by 28%–30% in RPE50 transfected with PKCδ
shRNA  (GH  and  FH),  as  compared  with  that  in  cells
transfected with control (lamin) shRNA (Figure 4C,D). In
contrast, transfection of the cells with shRNA of the other
PKC isozymes (90 plus 92, and D plus A2 for PKCα and
PKCβII, respectively) did not show any preventive effects.
Similar  results  were  obtained  using  ARPE19.  As
demonstrated  in  Figure  8,  treatment  of  EMB  for  5.0  h
dramatically  suppressed  ROS  uptake  in  ARPE19.  A
Figure 6. Extended time-course analysis
of ethambutol (EMB)-induced elevation
of membrane protein kinase C (PKCδ).
RPE50 cells were treated with 8.0 mM
EMB for 0, 1, 3, 6, and 24 h. A western
blot  of  membrane  PKC  δ  was
performed. A non-specific band in the
Ponceau S stained blot was included as
an  internal  control.  The  result  is
representative  of  two  repeated
experiments. The relative ratios of the
band intensity of PKC δ versus a non-
specific band, taking the ratio of time
zero as 1.0, are shown below.
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1571cotreatment with 2 μM Rottlerin greatly prevented EMB-
induced  reduction  of  ROS  uptake.  As  a  negative  control,
2 μM Rottlerin did not influence ROS uptake in the absence
of EMB (CON/rott). These results indicated that PKCδ was
specifically required for EMB-induced suppression of ROS
uptake in RPE.
Figure 7. Depletion of protein kinase C
(PKCα) and PKCδ by shRNA. RPE50
cells  were  transfected  with  none
(MOCK), or various shRNAs fragments
(either  alone  or  in  combination)  of
indicated PKC isozymes. Western blots
of PKCα (upper panel), PKCδ (middle
panel), or PKCβII (lower panel) were
performed using non-specific bands in
the Ponceau S stained blots as internal
controls. The relative ratios of the band
intensity  of  each  PKC  versus  a
nonspecific  band,  taking  the  ratio  of
MOCK as 1.0, are shown below. The
results  were  the  average  of  three
repeated  experiments  with  a  C.V.  of
6.0–8.0.
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1572EMB-induced elevation of cytosolic cathepsin D in a PKCδ-
dependent  manner:  One  intriguing  issue  with  regards  to
EMB-induced vacuolization was addressed by a recent report
suggesting that the vacuoles were derived from lysosomes
[10].  The  report  demonstrated  that  EMB  might  induce
lysosomal  membrane  permeabilization  (LMP)  resulting  in
leakage  of  lysosomal  content  and  subsequent  vacuolar
formation. One of the most abundant lysosome components
released into cytosol was the acid phosphatase cathepsin D
[10]. Thus, we further examined whether EMB may induce
cytoplasmic  release  of  cathepsin  D  and  whether  PKCδ  is
involved. As demonstrated in Figure 9A, cathepsin D can not
be detected in cytosol, in contrast with the high basal level of
cathepsin D in the total lysate of untreated RPE50. After
treatment with EMB for 30 min, cytosolic cathepsin D was
increased 2.0-fold and showed a further 2.4, 3.0, and 5.0-fold
increase at 1, 3, and 6 h, respectively, while total cathepsin D
was not influenced. However, cathepsin D was detected in the
crude  lysosomal  fraction  of  RPE50,  which  was  gradually
decreased by 40% after treatment of EMB for 1–3 h (Figure
10). Interestingly, pretreatment of RPE50 with 2 μM Rottlerin
suppressed the EMB-induced cytosolic elevation of cathepsin
D by 49% (p<0.05, ANOVA) at 3 h (Figure 9B), implicating
that this phenomenon was also mediated by PKCδ.
DISCUSSION
The role of RPE in EMB-induced adverse effects on retinas:
In  this  report,  we  identified  the  critical  signal  molecule
Figure 8. Inhibition of protein kinase C
(PKCδ) prevented ethambutol (EMB)-
induced  suppression  of  rod  outer
segments (ROS) uptake in ARPE 19.
The fluorescein isothiocyanate (FITC)-
labeled  ROS  were  added  to  the  cells
without  any  treatment  (CON),  in  the
presence of 8 mM EMB alone, EMB
plus  3  μM  Rottlerin  (EMB/rott),  or
Rottlerin alone (CON/rott) in ARPE19
for 5 h. The FITC-labeled ROS (green
dot) uptake by the cells were observed
under  a  phase  contrast  microscope
(200× magnification). The nuclei were
stained with PI (red) as counterstaining.
The figure shown was representative of
two repeated experiments.
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1573responsible for the toxic effects of EMB on RPE, which is
probably one of the most critical target cells involved in EMB-
induced retinopathy. Physiologically, RPE plays important
roles in the maintenance of the blood-retinal barrier and in the
transportation of trophic factors and nutrients to the retina.
Moreover,  RPE  closely  interacts  with  photoreceptors  to
maintain visual function. Specifically, RPE may serve as a
phagocyte for the uptake and catabolism of the daily shed rod
outer segments to recycle the visual pigments and maintain
homeostasis  of  photoreceptors  [26,27].  Thus,  long-term
administration of EMB may affect certain important functions
of RPE, such as phagocytic activity, leading to retinopathy.
This speculation was substantiated in our previous in vitro and
in vivo study [12].
Figure 9. Ethambutol (EMB) induced cytosolic release of cathepsin D in a protein kinase C (PKCδ)-dependent manner in RPE 50. RPE50
cells were untreated (con; B) or treated with 0.8 mM EMB for 0, 0.5, 1, 3, and 6 h (A) or 3 h with or without pretreatment of 2 μM Rottlerin
(B). Western blots of total cathepsin D (A) or cytosolic cathepsin D (A, B) were performed using ERK (A) or a nonspecific band in the Ponceau
S stained blot (B) as an internal control. The relative ratios of the band intensity of cathepsin D versus ERK (A) or the nonspecific band (B),
taking the ratio of time zero (A) or untreated (B) as 1.0, are shown below. The results were an average of three repeated experiments with a
C.V. of 6.0–8.0.
Figure 10. Ethambutol (EMB) induced
release of cathepsin D from lysosome in
RPE50 cells. RPE50 cells were treated
with 0.8 mM EMB for 0, 1, and 3 h. A
western blot of cathepsin D in the crude
lysosomal  fraction  was  performed.  A
nonspecific  band  in  the  Ponceau  S
stained blot was included as an internal
control. The relative ratios of the band
intensity  of  cathepsin  D  versus  the
nonspecific band, taking the ratio at time
zero as 1.0, are shown . The results were
an average of two repeated experiments
with a coefficient of variation (CV) of
6.0%–8.0%.
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1574Various  EMB-induced  toxic  effects  in  RPE  were  closely
related:  Our  results  demonstrated  that  EMB-induced
cytosolic vacuolization and reduction of phagocytosis in both
RPE50  and  ARPE19  were  mediated  by  PKCδ  (Figure  1,
Figure  2,  and  Figure  4).  This  strongly  implies  a  close
relationship between the two phenotypic changes. In a recent
study, the vacuoles induced by EMB were demonstrated to be
derived  from  lysosomes  with  increased  membrane
permeabilization  (LMP),  as  revealed  by  the  release  of
lysosomal components such as cathepsin D into cytosol [10].
On the other hand, lysosomes are responsible for degrading
the phagocytosed photoreceptor outer segment disks in RPE
via a phagosome–lysosomal fusion [28]. Taken together, it is
tempting  to  speculate  that  EMB  may  trigger  lysosomal
dysfunction and the subsequent reduction in the phagocytic
ability of RPE. Interestingly, our results demonstrated that
EMB might also induce the cytosolic release of lysosomal
cathepsin D in RPE50 in a PKCδ-dependent manner (Figure
9B). This finding further strengthens the notion that EMB-
induced cytosolic vacuolization, LMP, and the reduction of
phagocytosis are closely related cellular events regulated by
the same signal pathway.
Role of PKCδ in mediating pathological processes in RPE:
We found that PKCδ was the only PKC isozyme responsible
for EMB-induced toxic effects in RPE. Unlike PKCβ (which
stimulates growth) and PKCε (which acts as an oncogene and
promotes  tumors  in  nude  mice),  PKCδ  generally  slows
proliferation,  induces  cell  cycle  arrest,  enhances  the
differentiation of various cell lines [29-31], and is intimately
associated  with  DNA  damage-induced  apoptosis  [32].  In
addition, PKCδ plays an important role in several pathological
processes, including vascular complications associated with
diabetes  [33].  Moreover,  PKCδ  inhibitors  may  attenuate
reperfusion injury and may improve thrombolysis outcomes
[34].
Although EMB did not induce membrane translocation
of  PKCδ  (Figure  3A),  EMB-induced  gene  expression  of
PKCδ was observed at both the protein (Figure 3A) and RNA
(Figure 3B) level. Importantly, depletion of PKCδ expression
prevented  EMB-induced  toxic  effects,  including  vacuolar
formation and reduction of ROS uptake (Figure 2 and Figure
4,  respectively).  A  previous  study  also  demonstrated  that
activation  of  PKCδ  can  be  achieved  by  elevating  gene
expression. For example, p21 (RAS), through its downstream
effector PI3K, induces PKCδ expression and PKCδ activity
through Akt, which is required for cell survival [35].
In summary, we conclude that EMB induced toxic effects
on RPE in a PKCδ-dependent manner. In the future, it may be
possible  to  develop  pharmacological  inhibitors  against
PKCδ to prevent the adverse effects exerted by EMB on the
retina.
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